Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T‐ALL

Significant progress has been made in the diagnosis and treatment of the drug‐resistant and highly recurrent refractory T cell acute lymphoblastic leukemia (T‐ALL). Primary tumor cell‐derived induced pluripotent stem cells (iPSCs) have become very useful tumor models for cancer research including dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuemei, Wen, Feiqiu, Li, Zhu, Li, Weiran, Zhou, Meiling, Sun, Xizhuo, Zhao, Pan, Zou, Chang, Liu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487874/
https://www.ncbi.nlm.nih.gov/pubmed/35488386
http://dx.doi.org/10.1002/cam4.4712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487874/
https://www.ncbi.nlm.nih.gov/pubmed/35488386
http://dx.doi.org/10.1002/cam4.4712

Ejemplares similares